The Importance of Drug Exposure in the Development of Cytomegalovirus Resistance. (PubMed, Int J Antimicrob Agents) - May 16, 2025 - "This disease is routinely managed by antiviral agents including (val)ganciclovir, foscarnet, cidofovir, letermovir, and maribavir. With solid knowledge of these relationships, more predictive in vitro and in vivo markers of clinical efficacy can be identified. Additionally, pharmacokinetic-pharmacodynamic models and combination therapies should be further explored in to improve the management of CMV."
Journal • Review • Cytomegalovirus Infection • Transplantation
|
|
Anne-Grete Märtson; Katie Lynch
|